A novel drug for bacterial pneumonia | The Daily Starhttps://www.thedailystar.net/health/news/novel-drug-bacterial-pneumonia-1819069
2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
FDA approves new antibiotic to treat community-acquired bacterial pneumonia | FDAhttps://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-treat-community-acquired-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulin
Lefamulin: An Overview of a Lonely Soldierhttps://www.contagionlive.com/publications/contagion/2020/june/lefamulin-an-overview-of-a-lonely-soldier
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaPleuromutilin antibiotics
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP) Nasdaq:NBRVhttps://www.globenewswire.com/news-release/2019/08/19/1903735/0/en/Nabriva-Therapeutics-Receives-U-S-FDA-Approval-of-Xenleta-lefamulin-to-Treat-Community-Acquired-Bacteria-Pneumonia-CABP.html
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulinNabriva
Nabriva receives FDA approval for Xenletahttps://www.in-pharmatechnologist.com/Article/2019/08/22/Nabriva-receives-FDA-approval-for-Xenleta
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaNabriva
Nabriva scores its first FDA nod with novel antibiotic Xenleta | FiercePharmahttps://www.fiercepharma.com/marketing/nabriva-scores-fda-nod-for-novel-antibiotic-to-treat-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumoniaLefamulinNabriva

Showing topic

2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Antibiotic-resistant Streptococcus pneumoniaeLefamulin